Form4insider filings, from the source

Company · CIK 0001827635 · SIC 2834 — Pharmaceutical Preparations · NYSE

Veradermics, Inc · MANE

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $103.1M · 4net −$103.1M
$10k$10k$1M$1M$100M$100MbuyssalesAug 11Aug 12Aug 14Aug 15Aug 17Aug 18Aug 20

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 1, 2026 AForm 4 →Sep 3, 4:35 pm EDTDavid HollanderChief R&D Officer9,650——9,650—
Aug 20, 2026 XForm 4 →Aug 21, 6:11 pm EDTMONTANOVA CAPITAL, LLC +3Director300,000——612,033—
Aug 19, 2026 SForm 4 →Aug 21, 6:11 pm EDTMONTANOVA CAPITAL, LLC +3Director750,000$107.25$80,437,500461,033−61.9%
Aug 17, 2026 SForm 4 →Aug 18, 9:10 pm EDTTimothy August DursoChief Technical Officer43,500$107.82$4,690,00578,142−35.8%10b5-1
Aug 17, 2026 MForm 4 →Aug 18, 9:10 pm EDTTimothy August DursoChief Technical Officer3,452$12.19$42,080121,642—10b5-1
Aug 17, 2026 SForm 4 →Aug 18, 9:04 pm EDTReid Alexander WaldmanChief Executive Officer, Director67,500$107.86$7,280,713170,824−28.3%10b5-1
Aug 17, 2026 MForm 4 →Aug 18, 9:04 pm EDTReid Alexander WaldmanChief Executive Officer, Director3,452$12.19$42,080238,324—10b5-1
Aug 12, 2026 SForm 4 →Aug 14, 6:01 pm EDTJohn W ChildsDirector100,000$107.12$10,711,700194,117−34.0%

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 1, 2026 AForm 4 →Sep 3, 4:35 pm EDTDavid HollanderChief R&D Officer19,300——19,300—
Aug 20, 2026 XForm 4 →Aug 21, 6:11 pm EDTMONTANOVA CAPITAL, LLC +3Director300,000——0—
Aug 17, 2026 MForm 4 →Aug 18, 9:10 pm EDTTimothy August DursoChief Technical Officer3,452——0—10b5-1
Aug 17, 2026 MForm 4 →Aug 18, 9:04 pm EDTReid Alexander WaldmanChief Executive Officer, Director3,452——0—10b5-1